Cancer immunotherapy

drug R&D

Small Molecule Targeted Cancer Immunotherapy Draws the New Roadmap for Cancer Treatment

As an alternative to surgery, radiotherapy, and chemotherapy, tumor therapy via the immune pathway has made significant advances in recent years. Among the targeted drugs of immuno-oncology (IO), Ab drugs […]

Small Molecule Drugs for Cancer Immunotherapy

Progress and Promise: Small Molecule Drugs for Cancer Immunotherapy

Overview of cancer immunotherapy The most widely studied cancer immunotherapies are PD-1/PD-L1 immune checkpoint inhibitors and chimeric antigen receptor-T cell (CAR-T) therapy. With the expanded clinical applications, some defects of […]

New Progresses on Cancer Immunotherapy

New Progresses on Cancer Immunotherapy

1 Blocking the function of special proteins may increase the effectiveness of immunotherapy Immunotherapy can attack cancer cells by stimulating the patient’s own immune system, which can quickly alleviate the diseases […]

Checkpoint inhibitors in immunotherapy of ovarian cancer

Checkpoint inhibitors in immunotherapy of ovarian cancer

Ovarian cancer is a cancerous growth arising from numerous parts, mainly the outer lining of the ovary called germinal epithelium. It is the fifth leading cause of cancer-related death among women, which causes […]